Scientists at the University of Illinois at Urbana-Champaign report they have uncovered a protein that may aid efforts to fine-tune the use of immunotherapies for cancer. Their study in mice ...

The biotech will explore the potential of BI-1808 plus Keytruda in clear cell and high-grade serous ovarian cancer subtypes.

A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors ...

Researchers set out to investigate the association between treatment with TNF blockers and occurrence of cancer in a large sample of patients with RA. Their results indicate that biologic DMARD ...

Cancer-associated inflammation, in the form of local and systemic inflammatory responses, appear to be linked to tumour necrosis and have prognostic value in patients with colorectal cancer. However, ...

White blood cells are part of many immune system responses in the human body. New research shows that a specific type of those cells may cause brain cancer tissues to die – but that's not good news, ...

Impact of Rituximab and/or High-Dose Therapy With Autotransplant at Time of Relapse in Patients With Follicular Lymphoma: A GELA Study Cancer is a leading cause of premature human death and commands ...

Madrid, Spain, 13 June 2019: The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2019) suggest that overall cancer risk is not linked to tumour necrosis ...

A University of Pennsylvania research team has shown that it can kill tumor cells in mice by necrosis, rather than by inducing apoptosis, by giving them alkylating agents that block their energy ...